SCHEMBL7933533

SCHEMBL7933533

N#CC(CO)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
ALPG P10696 2/20 0.46
KMT2A Q03164 2/20 0.46
ESR1 P03372 5/20 0.44
ESR2 Q92731 5/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
CCR1 P32246 1/20 0.39
FFAR1 O14842 1/20 0.39
TRPA1 O75762 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12948243 0.84 KMT2A (0.43) ALDH1A1LMNASMN1; SMN2ALPGKMT2A
SCHEMBL1094322 0.79 ESR1 (0.44) ALDH1A1LMNAKMT2AESR1ESR2
SCHEMBL30564952 0.79 KMT2A (0.42) ALDH1A1LMNASMN1; SMN2ALPGKMT2A
SCHEMBL29061981 0.79 KMT2A (0.46) ALDH1A1LMNASMN1; SMN2ALPGKMT2A
SCHEMBL1095302 0.79 ESR2 (0.44) ALDH1A1LMNASMN1; SMN2KMT2AESR1
SCHEMBL953000 0.79 KMT2A (0.46) ALDH1A1LMNASMN1; SMN2ALPGKMT2A
SCHEMBL9451717 0.79 ESR1 (0.44) ALDH1A1KMT2AESR1ESR2MEN1
SCHEMBL23199874 0.78 TSHR (0.52) ALDH1A1LMNASMN1; SMN2KMT2AESR1
SCHEMBL1094363 0.78 TSHR (0.52) ALDH1A1LMNASMN1; SMN2KMT2AESR1
SCHEMBL31261480 0.78 TSHR (0.52) ALDH1A1LMNASMN1; SMN2KMT2AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
WO-2010056722-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306593-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 ALDH1A1 3613/4885LMNA 491/4885SMN1; SMN2 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.